US Patent:
20230029094, Jan 26, 2023
Inventors:
- Wilmington DE, US
Qun Li - Newark DE, US
Huaping Zhang - Newark DE, US
Hongwu Yu - Newark DE, US
International Classification:
A61K 31/519
Abstract:
The disclosure is directed to pharmaceutically acceptable salts of the compound of Formula I (I). Pharmaceutical compositions comprising pharmaceutically acceptable salts of the compound of Formula I, as well as methods of their use and preparation, are also described.